We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Phenoxide-Bridged Zinc(II)-Bis(dipicolylamine) Probes for Molecular Imaging of Cell Death
Authors
Clear, Kasey J.Harmatys, Kara M.
Rice, Douglas R.
Wolter, William R.
Suckow, Mark A.
Wang, Yuzhen
Rusckowski, Mary
Smith, Bradley D.
UMass Chan Affiliations
Department of RadiologyDocument Type
Journal ArticlePublication Date
2016-02-17
Metadata
Show full item recordAbstract
Cell death is involved in many pathological conditions, and there is a need for clinical and preclinical imaging agents that can target and report cell death. One of the best known biomarkers of cell death is exposure of the anionic phospholipid phosphatidylserine (PS) on the surface of dead and dying cells. Synthetic zinc(II)-bis(dipicolylamine) (Zn2BDPA) coordination complexes are known to selectively recognize PS-rich membranes and act as cell death molecular imaging agents. However, there is a need to improve in vivo imaging performance by selectively increasing target affinity and decreasing off-target accumulation. This present study compared the cell death targeting ability of two new deep-red fluorescent probes containing phenoxide-bridged Zn2BDPA complexes. One probe was a bivalent version of the other and associated more strongly with PS-rich liposome membranes. However, the bivalent probe exhibited self-quenching on the membrane surface, so the monovalent version produced brighter micrographs of dead and dying cells in cell culture and also better fluorescence imaging contrast in two living animal models of cell death (rat implanted tumor with necrotic core and mouse thymus atrophy). An (111)In-labeled radiotracer version of the monovalent probe also exhibited selective cell death targeting ability in the mouse thymus atrophy model, with relatively high amounts detected in dead and dying tissue and low off-target accumulation in nonclearance organs. The in vivo biodistribution profile is the most favorable yet reported for a Zn2BDPA complex; thus, the monovalent phenoxide-bridged Zn2BDPA scaffold is a promising candidate for further development as a cell death imaging agent in living subjects.Source
Bioconjug Chem. 2016 Feb 17;27(2):363-75. Epub 2015 Sep 11. Link to article on publisher's siteDOI
10.1021/acs.bioconjchem.5b00447Permanent Link to this Item
http://hdl.handle.net/20.500.14038/48126PubMed ID
26334386Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1021/acs.bioconjchem.5b00447